An open label phase Ib dose finding study of BI 836880 in combination with BI 754091 to characterize safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy in patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Cancer and in other solid tumors.

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))
  • Richardson, Gary E (Chief Investigator (CI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date1/07/20 → 31/12/24

Keywords

  • Medical oncology
  • Lung cancer
  • Clinical trial